Company Profiles

driven by the PitchBook Platform

Axikin Pharmaceuticals

Description

Operator of a biopharmaceutical firm. The company develops molecule therapeutics for respiratory, inflammatory and autoimmune diseases like allergic rhinitis and asthma.

2008

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$6.5M

Latest Deal Amount

$11.6M

Total Amount Raised

Description

Operator of a biopharmaceutical firm. The company develops molecule therapeutics for respiratory, inflammatory and autoimmune diseases like allergic rhinitis and asthma.

Website:

www.axikin.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

4940 Carroll Canyon Road Suite 100 San Diego, CA 92121United States +1 (858) 458-1890
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Axikin Pharmaceuticals's full profile, request a free trial.

Axikin Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Axikin Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Axikin Pharmaceuticals Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Mitsui Global InvestmentCorporate Venture CapitalMinority000 0000000 0000
Sanderling VenturesVenture CapitalMinority000 0000000 0000
Mitsui Global Investment Corporate Venture Capital
Sanderling Ventures Venture Capital

Axikin Pharmaceuticals Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Kevin Bacon Ph.DPresident, Founder, Chief Scientific Officer & Board Member
Stefen Boehme Ph.DDirector, Immunology
Tai Ly Ph.DSenior Director, Drug Development Technologies
Peter McWilliams Ph.DActing Chief Executive Officer & Chairman
Kevin Bacon Ph.D President, Founder, Chief Scientific Officer & Board Member
Stefen Boehme Ph.D Director, Immunology
Tai Ly Ph.D Senior Director, Drug Development Technologies
Peter McWilliams Ph.D Acting Chief Executive Officer & Chairman

Axikin Pharmaceuticals Board Members (2)

NameRepresentingRoleSinceContact
Info
Fred MiddletonSanderling VenturesManaging Director000 0000
Peter McWilliams Ph.DSelfActing Chief Executive Officer & Chairman000 0000
Fred Middleton Managing Director Sanderling Ventures
Peter McWilliams Ph.D Acting Chief Executive Officer & Chairman Self
Request full access to PitchBook